BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23083576)

  • 1. What is specific in hereditary breast cancer? High T2 signal intensity as a new semeiotic pattern?
    Trecate G; Agresti R; Suman L; Vergnaghi D; Valeri B; Marchesini M; Ferranti C; Ferraris C; Manoukian S; Scaperrotta G; ViganĂ² S; Panizza P
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S165-70. PubMed ID: 23083576
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI in high risk women: benefits and problems.
    Cortesi L; Pecchi A; De Matteis E; Filieri E; Battista R; Canossi B; Torricelli P; Federico M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S19-20. PubMed ID: 23083587
    [No Abstract]   [Full Text] [Related]  

  • 3. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast magnetic resonance imaging for screening high-risk women.
    Sung JS; Dershaw DD
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):509-17. PubMed ID: 23928241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI in B3 lesions, low grade DCIS, high DCIS: is MR selecting the dangerous cases?
    Zuiani C; Londero V; Linda A; Girometti R; Bazzocchi M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S189-91. PubMed ID: 23083586
    [No Abstract]   [Full Text] [Related]  

  • 6. The fibrotic focus in MR-mammography.
    Van Goethem M; Hufkens G; Verslegers I; Van Marck V; Biltjes I; Parizel PM
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S179-80. PubMed ID: 23083581
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
    Goffin J; Chappuis PO; Wong N; Foulkes WD
    J Natl Cancer Inst; 2001 Nov; 93(22):1754-5. PubMed ID: 11717339
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy--monitoring: clinical examination, ultrasound, mammography, MRI, elastography: only one, only few or all?
    Schulz-Wendtland R
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S147-8. PubMed ID: 23083568
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical indications: what is the evidence?
    Lehman CD
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S82-4. PubMed ID: 23083615
    [No Abstract]   [Full Text] [Related]  

  • 10. Can we use MR-mammography to predict nodal status?
    Carbonaro LA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S17-8. PubMed ID: 23083577
    [No Abstract]   [Full Text] [Related]  

  • 11. Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)?
    Houssami N; Wilson R
    Breast; 2007 Feb; 16(1):2-4. PubMed ID: 17189696
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical results of DTI.
    Shapiro-Feinberg M; Weisenberg N; Zehavi T; Furman-Haran E; Grobgeld D; Nissan N; Degani H
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S151-2. PubMed ID: 23083570
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
    Kuhl CK; Schmutzler RK; Leutner CC; Kempe A; Wardelmann E; Hocke A; Maringa M; Pfeifer U; Krebs D; Schild HH
    Radiology; 2000 Apr; 215(1):267-79. PubMed ID: 10751498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI in breast cancer.
    Gur D
    N Engl J Med; 2004 Nov; 351(21):2235-6; author reply 2235-6. PubMed ID: 15559961
    [No Abstract]   [Full Text] [Related]  

  • 16. The evaluation of women with familial risk of breast cancer.
    Boetes C
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):97-101. PubMed ID: 12585662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI before initial surgery outside of clinical trials: the real world!
    Cortesi L; De Matteis E; Cirilli C; Filieri E; Pecchi A; Battista R; Canossi B; Torricelli P; Federico M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S21-3. PubMed ID: 23083589
    [No Abstract]   [Full Text] [Related]  

  • 18. MR imaging in screening women at increased risk for breast cancer.
    Boetes C; Stoutjesdijk M
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):357-72, vii. PubMed ID: 11493425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates.
    Pediconi F; Miglio E; Telesca M; Luciani ML; Kirchin MA; Passariello R; Catalano C
    Invest Radiol; 2012 Feb; 47(2):128-35. PubMed ID: 21934515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
    J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.